🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Admit you’re old. Retweet if you know what this is…

Remote periosteal bleed…no need to WORKUP this benign process. Leave it alone!

The incredible process of making a wooden ball ⚽️

Beauty of Numbers

All the radiologists know the answer

First Model Y & Model 3 deliveries in Thailand 🇹🇭 tesla.com/en_th

Proud to author a new editorial JAMA Oncology jamanetwork.com/journals/jamao… Union for International #CancerControl ASCO Sylvester Comprehensive Cancer Center

Nirogacestat, a γ-Secretase Inhibitor for #Desmoid Tumors ⁦NEJM⁩ nejm.org/doi/full/10.10…

Subtype specific U.S. FDA approved and National Comprehensive Cancer Network (NCCN) guideline agents for #sarcoma patients by William Tap ESMO - Eur. Oncology

It's a wake-up call for #radiologists including myself !Dr Behrang Amini,MD/PhD view is true: In the real world (cat),anything unless statement #1 get you laughed at. In radiology,#1 is rare instead we teach our #residents by our weak examples,to be as non-declarative as possible

MSK RADIOGRAPHY PEARL: Posterior shoulder dislocation is difficult to diagnose on AP view. Axillary view is ideal but often not possible. Y-view needs to be near perfect (see below). Grashey and Velpeau views are very useful as well. SSR_RWG International Skeletal Society | ISS NYU_MSK Radiology Society of Skeletal Radiology

Thailand 🇹🇭

Please welcome Fabiano Nassar de Castro Cardoso, M.D., to our Sylvester Comprehensive Cancer Center #Sarcoma team. He's an experienced radiologist who makes #sarcoma patients life better through musculoskeletal oncoradiology. UMiami Health System Radiology physician-news.umiamihealth.org/dr-fabiano-nas…

⁦Stephen D. Nimer, MD⁩ Leads big ⁦Sylvester Comprehensive Cancer Center⁩ Center growth - ⁦Miami Today⁩ miamitodaynews.com/2023/08/29/ste…

mind blowing

Breaking: Today, the U.S. FDA approved the first therapy for adults with #DesmoidTumors. We are thankful to the patients, physicians, advocates, and SpringWorkers who helped make this achievement possible. bit.ly/3SZUgby

Breaking new ground in #MultipleMyeloma #research! C. Ola Landgren, M.D. shares the analysis of the Phase 2 Centaurus Study, shedding light on the efficacy and safety of daratumumab monotherapy in patients with intermediate-risk or high-risk smoldering multiple #myeloma. #ASH23